Abeona Therapeutics Inc vs ASML Holding NV — how do they compare? Abeona Therapeutics Inc trades at $7.57 (market cap $421.19M), while ASML Holding NV trades at $1,823.62 (market cap $689.17B). The key difference: ASML Holding NV is far larger — about 1636.2× Abeona Therapeutics Inc's market cap, and ASML Holding NV pays a 0.5% dividend while Abeona Therapeutics Inc pays none. Which is the better fit depends on your goals.
| ABEO | ASML | |
|---|---|---|
Market Cap | $421.19M | $689.17B |
Sector | Health | Technology |
52-Week High | $7.45 | $1.99K |
52-Week Low | $4.17 | $725.85 |
Enterprise Value | $276.10M | $682.70B |
Dividend Yield | — | 0.5% |
Trailing returns across standard periods
Latest headlines on both assets
Abeona Therapeutics develops gene and cell therapies for rare diseases. Its lead product, ZEVASKYN, is an FDA-approved therapy for recessive dystrophic epidermolysis bullosa (RDEB), a severe and life-threatening genetic skin disorder.
Read more on ABEO →Founded in 1984 and based in the Netherlands, ASML is the leader in photolithography systems used in the manufacturing of semiconductors. Photolithography is the process in which a light source is used to expose circuit patterns from a photomask onto a semiconductor wafer. The latest technological advances in this segment allow chipmakers to continually increase the number of transistors on the same area of silicon, with lithography historically representing a meaningful portion of the cost of making cutting-edge chips. Chipmakers require next-generation EUV lithography tools from ASML to continue past the 5-nanometer process node. ASML's products are used at every major semiconductor manufacturer, including Intel, Samsung, and TSMC.
Read more on ASML →